Mirati Therapeutics, Inc.

PRINCIPAL FINANCIAL GROUP INC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/7/2024

Shares

10,784

Value ($000)

634

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/7/2024	634	0.0%	10,784	12/31/2023
2023 Q3	11/2/2023	494	0.0%	11,351	9/30/2023
2023 Q2	8/7/2023	397	0.0%	10,996	6/30/2023
2023 Q1	5/9/2023	453	0.0%	12,172	3/31/2023
2022 Q4	2/9/2023	566	0.0%	12,482	12/31/2022
2022 Q3	11/9/2022	789	0.0%	11,290	9/30/2022
2022 Q2	8/10/2022	724	0.0%	10,791	6/30/2022
2022 Q1	5/9/2022	829	0.0%	10,088	3/31/2022
2021 Q4	2/9/2022	1,532	0.0%	10,440	12/31/2021
2021 Q3	11/9/2021	2,491	0.0%	14,083	9/30/2021
2021 Q2	8/10/2021	2,573	0.0%	15,931	6/30/2021
2021 Q1	5/10/2021	9,720	0.0%	56,743	3/31/2021
2020 Q4	2/23/2021	5,265	0.0%	23,970	12/31/2020
2020 Q3	11/6/2020	3,835	0.0%	23,094	9/30/2020
2020 Q2	8/5/2020	2,707	0.0%	23,707	6/30/2020
2020 Q1	5/12/2020	1,326	0.0%	17,248	3/31/2020
2019 Q4	2/5/2020	1,918	0.0%	14,884	12/31/2019